Macrophages and T lymphocytes are the predominant cells in intimal arteritis of resected renal allografts undergoing acute rejection

Transplant Immunology

Volumn 25, Issue 1, 2011, Pages 42-48

  Sun, Hua jun ^a   Zhou, Tong ^a   Wang, Yong ^b   Fu, Yao wen ^b   Jiang, Yun peng ^a   Zhang, Li hong ^a   Zhang, Cheng bin ^a   Zhou, Hong lan ^b   Gao, Bao shan ^b   Shi, Ying ai ^a   Wu, Shan ^a  

^a Jilin University   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Antibody mediated rejection; Glomerulitis; Immunological phenotypes; Intimal arteritis; Kidney transplantation; Unfavorable outcome

Indexed keywords

CD3 ANTIGEN;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; ARTERITIS; ARTERY LESION; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GLOMERULITIS; GRAFT FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTIMAL ARTERITIS; KIDNEY ALLOGRAFT REJECTION; LYMPHOCYTIC INFILTRATION; MACROPHAGE FUNCTION; MALE; NATURAL KILLER CELL; NEPHRECTOMY; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; ARTERITIS; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; FEMALE; GLOMERULONEPHRITIS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PLASMA CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 79959659933     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2011.04.002     Document Type: Article

References (35)

1. Saemann M.D., Sunder-Plassmann G. Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis. Transpl Immunol 2008, 20:14-20.
2. Sayegh M.H., Carpenter C.B. Transplantation 50 years later-progress, challenges, and promises. N Engl J Med 2004, 351:2761-2766.
3. D'Agati V.D., Jennette J.C., Silva F.G. Non-neoplastic Kidney Diseases 2005, 668-677. American -Registry-of-Pathology, Armed-Forces-Institute-of-Pathology, Washington, DC.
4. Jeannet M., Pinn V.W., Flax M.H., Winn H.J., Russell P.S. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970, 282:111-117.
5. Manning D.D., Reed N.D., Shaffer C.F. Maintenance of skin xenografts of widely divergent phylogenetic origin of congenitally athymic (nude) mice. J Exp Med 1973, 138:488-494.
6. Tilney N.L., Garovoy M.R., Busch G.J., Strom T.B., Graves M.J., Carpenter C.B. Rejected human renal allografts: recovery and characteristics of infiltrating cells and antibody. Transplantation 1979, 28:421-426.
7. Chadban S., Morris R., Hirsch H.H., Bunnapradist S., Arns W., Budde K. Immunosuppression in renal transplantation: some aspects for the modern era. Transplant Rev (Orlando) 2008, 22:241-251.
8. Kozakowski N., Bohmig G.A., Exner M., Soleiman A., Huttary N., Nagy-Bojarszky K., et al. Monocytes/macrophages in kidney allograft intimal arteritis: no association with markers of humoral rejection or with inferior outcome. Nephrol Dial Transplant 2009, 24:1979-1986.
9. Matheson P.J., Dittmer I.D., Beaumont B.W., Merrilees M.J., Pilmore H.L. The macrophage is the predominant inflammatory cell in renal allograft intimal arteritis. Transplantation 2005, 79:1658-1662.
10. Regele H., Exner M., Watschinger B., Wenter C., Wahrmann M., Osterreicher C., et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001, 16:2058-2066.
11. Mason D.Y., Cordell J.L., Gaulard P., Tse A.G., Brown M.H. Immunohistological detection of human cytotoxic/suppressor T cells using antibodies to a CD8 peptide sequence. J Clin Pathol 1992, 45:1084-1088.
12. Cartun R.W., Coles F.B., Pastuszak W.T. Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol 1987, 129:415-421.
13. Turley H., Jones M., Erber W., Mayne K., de Waele M., Gatter K. VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol 1994, 47:418-422.
14. Krugliak L., Meyer P.R., Taylor C.R. The distribution of lysozyme, alpha-1-antitrypsin, and alpha-1-antichymotrypsin in normal hematopoietic cells and in myeloid leukemias: an immunoperoxidase study on cytocentrifuge preparations, smears, and paraffin sections. Am J Hematol 1986, 21:99-109.
15. Chuang S.S., Li C.Y. Useful panel of antibodies for the classification of acute leukemia by immunohistochemical methods in bone marrow trephine biopsy specimens. Am J Clin Pathol 1997, 107:410-418.
16. Schienle H.W., Stein N., Muller-Ruchholtz W. Neutrophil granulocytic cell antigen defined by a monoclonal antibody-its distribution within normal haemic and non-haemic tissue. J Clin Pathol 1982, 35:959-966.
17. Loy T.S., Darkow G.V., Spollen L.E., Diaz-Arias A.A. Immunostaining for Leu-7 in the diagnosis of thyroid carcinoma. Arch Pathol Lab Med 1994, 118:172-174.
18. Racusen L.C., Solez K., Colvin R.B., Bonsib S.M., Castro M.C., Cavallo T., et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999, 55:713-723.
19. Solez K., Colvin R.B., Racusen L.C., Haas M., Sis B., Mengel M., et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008, 8:753-760.
20. D'Agati V.D., Jennette J.C., Silva F.G. Non-neoplastic Kidney Diseases 2005, 667. American -Registry-of-Pathology, Armed-Forces-Institute-of-Pathology, Washington, DC.
21. Halloran P.F., Wadgymar A., Ritchie S., Falk J., Solez K., Srinivasa N.S. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation 1990, 49:85-91.
22. Mauiyyedi S., Crespo M., Collins A.B., Schneeberger E.E., Pascual M.A., Saidman S.L., et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002, 13:779-787.
23. Crespo M., Pascual M., Tolkoff-Rubin N., Mauiyyedi S., Collins A.B., Fitzpatrick D., et al. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation 2001, 71:652-658.
24. Bohmig G.A., Regele H., Exner M., Derhartunian V., Kletzmayr J., Saemann M.D., et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J Am Soc Nephrol 2001, 12:2482-2489.
25. Sis B., Mengel M., Haas M., Colvin R.B., Halloran P.F., Racusen L.C., et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010, 10:464-471.
26. Strom T.B., Tilney N.L., Carpenter C.B., Busch G.J. Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med 1975, 292:1257-1263.
27. von Willebrand E., Hayry P. Composition and in vitro cytotoxicity of cellular infiltrates in rejecting human kidney allografts. Cell Immunol 1978, 41:358-372.
28. Brown K., Sacks S.H., Wong W. Extensive and bidirectional transfer of major histocompatibility complex class II molecules between donor and recipient cells in vivo following solid organ transplantation. FASEB J 2008, 22:3776-3784.
29. Jose M.D., Ikezumi Y., van Rooijen N., Atkins R.C., Chadban S.J. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003, 76:1015-1022.
30. Romagnani P., Pupilli C., Lasagni L., Baccari M.C., Bellini F., Amorosi A., et al. Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. J Pathol 1999, 187:345-350.
31. Pilmore H.L., Yan Y., Eris J.M., Hennessy A., McCaughan G.W., Bishop G.A., et al. Time course of upregulation of fibrogenic growth factors and cellular infiltration in a rodent model of chronic renal allograft rejection. Transpl Immunol 2002, 10:245-254.
32. Qi F., Adair A., Ferenbach D., Vass D.G., Mylonas K.J., Kipari T., et al. Depletion of cells of monocyte lineage prevents loss of renal microvasculature in murine kidney transplantation. Transplantation 2008, 86:1267-1274.
33. Lefaucheur C., Nochy D., Hill G.S., Suberbielle-Boissel C., Antoine C., Charron D., et al. Determinants of poor graft outcome in patients with antibody-mediated acute rejection. Am J Transplant 2007, 7:832-841.
34. Gibson I.W., Gwinner W., Br"ocker V., Sis B., Riopel J., Roberts I.S.D., et al. Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. Am J Transplant 2008, 8:819-825.
35. Tinckam K.J., Djurdjev O., Magil A.B. Glomerular monocytes predict worse outcomes after acute renal allograft rejection independent of C4d status. Kidney Int 2005, 68:1866-1874.